These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 18690302)

  • 1. Activity of propolis in an experimental model of pneumocystosis.
    Oguzkaya-Artan M; Nedret Koc A; Silici S; Ozturk A
    Saudi Med J; 2008 Aug; 29(8):1115-8. PubMed ID: 18690302
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inoculated mouse model of Pneumocystis carinii pneumonia.
    Bartlett MS; Queener SF; Durkin MM; Shaw MM; Smith JW
    J Protozool; 1991; 38(6):130S-131S. PubMed ID: 1818136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunological regulation and treatment of Brucea javanica and Fructus Psoraleae on rats with Pneumocystis carinii pneumonia].
    Qin YH; Cui Y; Ren YX; Zhang XL; Wang Y; Zheng XY; Chen XW; Sun M
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Feb; 24(1):59-62. PubMed ID: 16866148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of CD40 ligand and other immunomodulators on Pneumocystis carinii infection in rat model.
    Oz HS; Hughes WT; Rehg JE; Thomas EK
    Microb Pathog; 2000 Sep; 29(3):187-90. PubMed ID: 10968950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Employment of terbinafine against Pneumocystis carinii infection in rat models.
    Contini C; Colombo D; Cultrera R; Prini E; Sechi T; Angelici E; Canipari R
    Br J Dermatol; 1996 Jun; 134 Suppl 46():30-2; discussion 40. PubMed ID: 8763466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Treatment of pneumocystosis: preclinical evaluation].
    Girard PM; Brun-Pascaud M; Roux P
    Rev Pneumol Clin; 1991; 47(3):109-14. PubMed ID: 1957102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatal spontaneous pneumocystosis in nude rats.
    Furuta T; Fujita M; Machii K; Kobayashi K; Kojima S; Ueda K
    Lab Anim Sci; 1993 Dec; 43(6):551-6. PubMed ID: 8158979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic combinations of Ro 11-8958 and other dihydrofolate reductase inhibitors with sulfamethoxazole and dapsone for therapy of experimental pneumocystosis.
    Walzer PD; Foy J; Steele P; White M
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1436-43. PubMed ID: 8363372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A rat model for combined Trypanosoma cruzi and Pneumocystis carinii infection.
    Oz HS; Hughes WT; Varilek GW
    Microb Pathog; 2000 Dec; 29(6):363-5. PubMed ID: 11095921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Presence of Pneumocystis carinii and Pneumocystis wakefieldiae DNA in the extrapulmonary tissues of immunocompromised laboratory rats].
    Gołab E
    Wiad Parazytol; 2009; 55(2):167-71. PubMed ID: 19670532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Electron microscopical observation on rats with Pneumocystis carinii pneumonia treated with Brucea javanica and Fructus Psoraleae].
    Ren YX; Qin YH; Zheng LL; Dai XD; Tao L; Chen YF; Cui Y
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2006 Dec; 24(6):473-5. PubMed ID: 17366985
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study on the changes of soluble intercellular adhesion molecule-1 level in sera of rats infected with Pneumocystis carinii].
    Liu KQ; Yin WD; Xue GP; Zhang JS
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2007 Feb; 25(1):27-31, 35. PubMed ID: 17639695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The anti-inflammatory agent Propolis improves wound healing in a rodent model of experimental diabetes.
    McLennan SV; Bonner J; Milne S; Lo L; Charlton A; Kurup S; Jia J; Yue DK; Twigg SM
    Wound Repair Regen; 2008; 16(5):706-13. PubMed ID: 19128266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of sordarins in experimental models of candidiasis, aspergillosis, and pneumocystosis.
    Martinez A; Aviles P; Jimenez E; Caballero J; Gargallo-Viola D
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3389-94. PubMed ID: 11083645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of rat model for Pneumocystis carinii infection and cloning of the surface glycoprotein A gene of Pneumocystis carinii.
    Ouyang LS; Mo QY; Peng HJ; Chen XG; Shen SM
    Di Yi Jun Yi Da Xue Xue Bao; 2002 May; 22(5):427-9. PubMed ID: 12390704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Respiratory and pulmonary alterations in experimental Pneumocystis carinii pneumonia in rats.
    Brun-Pascaud M; Pocidalo JJ; Kernbaum S
    Bull Eur Physiopathol Respir; 1985; 21(1):37-41. PubMed ID: 3919791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Guanylhydrazones in therapy of Pneumocystis carinii pneumonia in immunosuppressed rats.
    Walzer PD; Foy J; Runck J; Steele P; White M; Klein RS; Otter BA; Sundberg RJ
    Antimicrob Agents Chemother; 1994 Nov; 38(11):2572-6. PubMed ID: 7872750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pathomorphology of experimental pneumocystosis and cytogenesis of the pathogen Pneumocystis carinii].
    Arabiĭskiĭ RA; Semenova LA; Mikhaĭlova MA
    Arkh Patol; 1991; 53(2):33-7. PubMed ID: 2069524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rat model for dual opportunistic pathogen prophylaxis: Cryptosporidium parvum and Pneumocystis carinii.
    Oz HS; Hughes WT; Rehg JE
    Lab Anim Sci; 1999 Jun; 49(3):331-4. PubMed ID: 10403453
    [No Abstract]   [Full Text] [Related]  

  • 20. Furazolidone and nitrofurantoin in the treatment of experimental Pneumocystis carinii pneumonia.
    Walzer PD; Kim CK; Foy J; Zhang JL
    Antimicrob Agents Chemother; 1991 Jan; 35(1):158-63. PubMed ID: 2014971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.